Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4+ T cells against the swine-origin H1N1 influenza virus

Vaccine

Volumn 29, Issue 17, 2011, Pages 3299-3309

  Schanen, Brian C ^a   De Groot, Anne S ^b,c,d   Moise, L ^b,d   Ardito, Matt ^b   McClaine, Elizabeth ^b   Martin, William ^b   Wittman, Vaughan ^a   Warren, William L ^a   Drake, Donald R ^a  

^a SANOFI PASTEUR   (France)

^b EpiVax Inc   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Cross reactive; H1N1; Human; Influenza; Informatics; Pandemic; T cells

Indexed keywords

EPITOPE; HEMAGGLUTININ; HLA DR ANTIGEN; INFLUENZA VACCINE;

ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPUTER MODEL; CONTROLLED STUDY; CROSS REACTION; HAPLOTYPE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; INFORMATION SYSTEM; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TECHNIQUE; VIRUS STRAIN;

ADULT; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; CROSS PROTECTION; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MIDDLE AGED;

EID: 79954623255     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.019     Document Type: Article

References (49)

1. Memoli M.J., Tumpey T.M., Jagger B.W., Dugan V.G., Sheng Z.M., Qi L., et al. An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. Virology 2009, 393(2):338-345.
2. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325(5937):197-201.
3. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361(20):1945-1952.
4. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460(7258):1021-1025.
5. Katz J., Hancock K., Veguilla V., Zhong W., Lu X.H., Sun H., et al. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009, 58(19):521-524.
6. Greenbaum J.A., Kotturi M.F., Kim Y., Oseroff C., Vaughan K., Salimi N., et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci USA 2009, 106(48):20365-20370.
7. Jain S., Kamimoto L., Bramley A.M., Schmitz A.M., Benoit S.R., Louie J., et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361(20):1935-1944.
8. Ellebedy AH, Ducatez MF, Duan S, Stigger-Rosser E, Rubrum AM, Govorkova EA, et al. Impact of prior seasonal influenza vaccination and infection on pandemic A(H1N1) influenza virus replication in ferrets. Vaccine 2010, in press.
9. De Groot A.S., Ardito M., McClaine E.M., Moise L., Martin W.D. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine 2009, 27(42):5740-5747.
10. Moser J.M., Sassano E.R., Leistritz del C., Eatrides J.M., Phogat S., Koff W., et al. Optimization of a dendritic cell-based assay for the in vitro priming of naive human CD4+ T cells. J Immunol Methods 2010, 353(1-2):8-19.
11. Schanen B.C., Drake D.R. A novel approach for the generation of human dendritic cells from blood monocytes in the absence of exogenous factors. J Immunol Methods 2008, 335(1-2):53-64.
12. Sette A., Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 1999, 50(3-4):201-212.
13. De Groot A.S., Jesdale B.M., Szu E., Schafer J.R., Chicz R.M., Deocampo G. An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. AIDS Res Hum Retroviruses 1997, 13(7):529-531.
14. Schafer J.R., Jesdale B.M., George J.A., Kouttab N.M., De Groot A.S. Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix. Vaccine 1998, 16(19):1880-1884.
15. Sturniolo T., Bono E., Ding J., Raddrizzani L., Tuereci O., Sahin U., et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 1999, 17(6):555-561.
16. De Groot A.S., Knopp P.M., Martin W. De-immunization of therapeutic proteins by T-cell epitope modification. Dev Biol (Basel) 2005, 122:171-194.
17. De Groot A.S., Martin W. Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics. Clin Immunol 2009, 131(2):189-201.
18. De Groot A.S., McMurry J., Marcon L., Franco J., Rivera D., Kutzler M., et al. Developing an epitope-driven tuberculosis (TB) vaccine. Vaccine 2005, 23(17-18):2121-2131.
19. Moise L., McMurry J.A., Buus S., Frey S., Martin W.D., De Groot A.S. In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes. Vaccine 2009, 27(46):6471-6479.
20. De Groot A.S., Rivera D.S., McMurry J.A., Buus S., Martin W. Identification of immunogenic HLA-B7 " Achilles' heel" epitopes within highly conserved regions of HIV. Vaccine 2008, 26(24):3059-3071.
21. McMurry J.A., Gregory S.H., Moise L., Rivera D., Buus S., De Groot A.S. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine. Vaccine 2007, 25(16):3179-3191.
22. Cohen T., Moise L., Ardito M., Martin W., De Groot A.S. A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: individualized T cell epitope measure (iTEM). J Biomed Biotechnol 2010, pii. 961752.
23. Richards K.A., Topham D., Chaves F.A., Sant A.J. Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. J Immunol 2010, 185(9):4998-5002.
24. Tu W., Mao H., Zheng J., Liu Y., Chiu S.S., Qin G., et al. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 2010, 84(13):6527-6535.
25. Ge X., Tan V., Bollyky P.L., Standifer N.E., James E.A., Kwok W.W. Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J Virol 2010, 84(7):3312-3319.
26. Cusick M.F., Wang S., Eckels D.D. In vitro responses to avian influenza H5 by human CD4 T cells. J Immunol 2009, 183(10):6432-6441.
27. Gioia C., Castilletti C., Tempestilli M., Piacentini P., Bordi L., Chiappini R., et al. Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza. Emerg Infect Dis 2008, 14(1):121-128.
28. Jameson J., Cruz J., Terajima M., Ennis F.A. Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. J Immunol 1999, 162(12):7578-7583.
29. Richards K.A., Chaves F.A., Krafcik F.R., Topham D.J., Lazarski C.A., Sant A.J. Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin. J Virol 2007, 81(14):7608-7619.
30. Richards K.A., Chaves F.A., Sant A.J. Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus. J Virol 2009, 83(13):6566-6577.
31. Roti M., Yang J., Berger D., Huston L., James E.A., Kwok W.W. Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. J Immunol 2008, 180(3):1758-1768.
32. Schneider C., Van Regenmortel M.H. Immunogenicity of free synthetic peptides corresponding to T helper epitopes of the influenza HA 1 subunit. Induction of virus cross reacting CD4+ T lymphocytes in mice. Arch Virol 1992, 125(1-4):103-119.
33. Alexander J., Bilsel P., del Guercio M.F., Stewart S., Marinkovic-Petrovic A., Southwood S., et al. Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice. Vaccine 2010, 28(3):664-672.
34. Belz G.T., Wodarz D., Diaz G., Nowak M.A., Doherty P.C. Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol 2002, 76(23):12388-12393.
35. Brooks J.W., Hamilton-Easton A.M., Christensen J.P., Cardin R.D., Hardy C.L., Doherty P.C. Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome. J Virol 1999, 73(11):9650-9654.
36. Cardin R.D., Brooks J.W., Sarawar S.R., Doherty P.C. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med 1996, 184(3):863-871.
37. Ellebedy A.H., Fabrizio T., Kayali G., Oguin T., Brown S., Rehg J., et al. Contemporary seasonal A (H1N1) influenza virus infection primes for a more robust response to split inactivated pandemic A(H1N1) vaccination in ferrets. Clin Vaccine Immunol 2010, 17(12):1998-2006.
38. Rasmussen I.B., Lunde E., Michaelsen T.E., Bogen B., Sandlie I. The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination. Proc Natl Acad Sci USA 2001, 98(18):10296-10301.
39. Marshall D., Sealy R., Sangster M., Coleclough C. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization. J Immunol 1999, 163(9):4673-4682.
40. Boon A.C., de Mutsert G., van Baarle D., Smith D.J., Lapedes A.S., Fouchier R.A., et al. Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes. J Immunol 2004, 172(4):2453-2460.
41. Kreijtz J.H., Bodewes R., van Amerongen G., Kuiken T., Fouchier R.A., Osterhaus A.D., et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 2007, 25(4):612-620.
42. Ulmer J.B., Fu T.M., Deck R.R., Friedman A., Guan L., DeWitt C., et al. Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J Virol 1998, 72(7):5648-5653.
43. Goy K., Von Bibra S., Lewis J., Laurie K., Barr I., Anderson D., et al. Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza. Influenza Other Respir Viruses 2008, 2(4):115-125.
44. Zinckgraf J.W., Sposato M., Zielinski V., Powell D., Treanor J.J., von Hofe E. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination. Vaccine 2009, 27(39):5393-5401.
45. Otero M., Calarota S.A., Dai A., De Groot A.S., Boyer J.D., Weiner D.B. Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy. Vaccine 2006, 24(21):4461-4470.
46. Meister G.E., Roberts C.G., Berzofsky J.A., De Groot A.S. Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. Vaccine 1995, 13(6):581-591.
47. Bond K.B., Sriwanthana B., Hodge T.W., De Groot A.S., Mastro T.D., Young N.L., et al. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais. AIDS Res Hum Retroviruses 2001, 17(8):703-717.
48. Dong Y., Demaria S., Sun X., Santori F.R., Jesdale B.M., De Groot A.S., et al. HLA-A2-restricted CD8+ -cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase. Infect Immun 2004, 72(4):2412-2415.
49. McMurry J.A., Johansson B.E., De Groot A.S. A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A. Hum Vaccin 2008, 4(2):148-157.